Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036272

Chief Commercial Officer gave up 11,570 shares (to pay taxes)

  • Chief Commercial Officer acquired 42,083 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vavricka John Chief Commercial Officer 2026-01-31 Option exercise +42,083 94,164 D
Vavricka John Chief Commercial Officer 2026-01-31 Shares withheld for taxes −11,570 $4.24 $49,057 82,594 D
Derivatives
Vavricka John Chief Commercial Officer 2026-01-31 Option exercise · Restricted Stock Units −33,333 0 D
Vavricka John Chief Commercial Officer 2026-01-31 Option exercise · Restricted Stock Units −8,750 0 D
Vavricka John Chief Commercial Officer 2026-01-31 Grant or award · Stock Option (Right to Buy) +119,520 119,520 D
Loading xslF345X05/ownership.xml…